These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6301008)

  • 41. Hepatitis b surface antigen and alphafetoprotein levels in the serum of healthy women.
    Kaklamani E; Zhong-Tang Z; Trichopoulos D; Koumantaki I; Kyriakidou A
    Oncology; 1984; 41(3):176-9. PubMed ID: 6203074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India--an autopsy study.
    Sundaram C; Reddy CR; Ramana GV; Benerjea S; Venkataratnam G; Kumari GS; Reddy BS; Bhaskaran CS
    Indian J Pathol Microbiol; 1990 Oct; 33(4):334-8. PubMed ID: 1966741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
    Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
    Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.
    Alward WL; McMahon BJ; Hall DB; Heyward WL; Francis DP; Bender TR
    J Infect Dis; 1985 Apr; 151(4):604-9. PubMed ID: 2982971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [HBs antigen: marker of the relation between hepatitis B virus and primary cancer of the liver: the situation in Brazzaville in 1984].
    Gombe CM
    IARC Sci Publ; 1984; (63):221-6. PubMed ID: 6100270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.
    Zaman SN; Melia WM; Johnson RD; Portmann BC; Johnson PJ; Williams R
    Lancet; 1985 Jun; 1(8442):1357-60. PubMed ID: 2861313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occult hepatitis B virus infection and hepatocellular carcinoma development in patients with chronic hepatitis C.
    Raimondo G; Pollicino T; Levrero M; Craxì A
    Hepatology; 2011 Jul; 54(1):373-4; author reply 374. PubMed ID: 21520203
    [No Abstract]   [Full Text] [Related]  

  • 48. Detection of soluble TRAIL in HBV infected patients and its clinical implications.
    Han LH; Sun WS; Ma CH; Zhang LN; Liu SX; Zhang Q; Gao LF; Chen YH
    World J Gastroenterol; 2002 Dec; 8(6):1077-80. PubMed ID: 12439929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathobiology of hepatitis B virus.
    Gerber MA; Thung SN
    Pathobiol Annu; 1981; 11():197-228. PubMed ID: 6276845
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum iron levels and response to hepatitis B virus.
    Felton C; Lustbader ED; Merten C; Blumberg BS
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2438-41. PubMed ID: 287082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Viral pathogenesis of hepatocellular carcinoma in the United States.
    Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER
    Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Epidemiological analysis of the etiological relationship between primary hepatocarcinoma and hepatitis B virus].
    Ding ZR
    Zhonghua Liu Xing Bing Xue Za Zhi; 1984 Jun; 5(3):146-9. PubMed ID: 6097361
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hepatocellular carcinoma and correlations with virus B infection, alcoholism and other possible toxic agents: study of 76 cases].
    Giuliani-Piccari G; Spongano P; Formica G; Macchia S; Simoni S; Dal Monte PR
    G Clin Med; 1981 Feb; 62(2):103-11. PubMed ID: 6165640
    [No Abstract]   [Full Text] [Related]  

  • 55. [A study of the correlation between primary hepatocellular carcinoma and hepatitis B].
    Lu CQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Feb; 9(1):5-7. PubMed ID: 2838172
    [No Abstract]   [Full Text] [Related]  

  • 56. Changes in serum iron levels due to infection with hepatitis B virus.
    Blumberg BS; Lustbader ED; Whitford PL
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3222-4. PubMed ID: 6942427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Higaki I; Takemura S; Yamamoto T; Nishiguchi S; Kinoshita H
    Dig Surg; 2001; 18(1):26-33. PubMed ID: 11244256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal serum iron markers in chronic hepatitis B virus infection may be because of liver injury.
    Mao W; Hu Y; Lou Y; Chen Y; Zhang J
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):130-6. PubMed ID: 25419642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of hepatocellular carcinoma complicating hepatitis B infection in a nine-year-old boy.
    Trounce JQ; Flower AJ; Shannon RS; Tanner MS
    Q J Med; 1985 Nov; 57(223):791-4. PubMed ID: 3001813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.